Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: data from a randomized, Phase III study.
Esposito S, Marchisio P, Montinaro V, Bianchini S, Weverling GJ, Pariani E, Amendola A, Fabiano V, Pivetti V, Zanetti A, Zuccotti GV. Esposito S, et al. Among authors: bianchini s. Vaccine. 2012 Nov 19;30(49):7005-12. doi: 10.1016/j.vaccine.2012.09.069. Epub 2012 Oct 8. Vaccine. 2012. PMID: 23059357 Clinical Trial.
The use of pediatric short-stay observation in Italy.
Pinto L, Bianchini S, Barbieri MA, Cherchi G, Miceli A, Mirauda MP, Russotto VS, Raffaldi I, Zangardi T, Perri D, Agostiniani R, Rugolotto S, Cardinale F, Zampogna S, Staiano A. Pinto L, et al. Among authors: bianchini s. Ital J Pediatr. 2023 Mar 21;49(1):34. doi: 10.1186/s13052-023-01441-8. Ital J Pediatr. 2023. PMID: 36941670 Free PMC article.
Efficacy of injectable trivalent virosomal-adjuvanted inactivated influenza vaccine in preventing acute otitis media in children with recurrent complicated or noncomplicated acute otitis media.
Marchisio P, Esposito S, Bianchini S, Dusi E, Fusi M, Nazzari E, Picchi R, Galeone C, Principi N. Marchisio P, et al. Among authors: bianchini s. Pediatr Infect Dis J. 2009 Oct;28(10):855-9. doi: 10.1097/INF.0b013e3181a487b4. Pediatr Infect Dis J. 2009. PMID: 19564812 Clinical Trial.
Insights into infectious otitis media.
Marchisio P, Bianchini S, Capaccio P, Esposito S, Fusi M, Nazzari E, Torretta S, Principi N. Marchisio P, et al. Among authors: bianchini s. Int J Immunopathol Pharmacol. 2010 Jan-Mar;23(1 Suppl):20-3. Int J Immunopathol Pharmacol. 2010. PMID: 20152074 Review.
A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6-35 months.
Esposito S, Marchisio P, Ansaldi F, Bianchini S, Pacei M, Baggi E, Trabattoni D, Icardi G, Principi N. Esposito S, et al. Among authors: bianchini s. Vaccine. 2010 Aug 31;28(38):6137-44. doi: 10.1016/j.vaccine.2010.07.041. Epub 2010 Jul 29. Vaccine. 2010. PMID: 20670909 Clinical Trial.
Pathophysiology, favoring factors, and associated disorders in otorhinosinusology.
Gelardi M, Marchisio P, Caimmi D, Incorvaia C, Albertario G, Bianchini S, Caimmi S, Celani C, Esposito S, Fattizzo M, Fiorella ML, Frati F, Labò E, Leo G, Licari A, Marseglia A, Piacentini E, Pignataro L, Quaranta N, Tenconi R, Torretta S, Marseglia GL, Principi N. Gelardi M, et al. Among authors: bianchini s. Pediatr Allergy Immunol. 2012 Aug;23 Suppl 22:5-16. doi: 10.1111/j.1399-3038.2012.01323.x. Pediatr Allergy Immunol. 2012. PMID: 22762848 Review.
135 results